Cargando…
Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice
There is currently no simple, widely available screening method for Alzheimer’s disease (AD), partly because the diagnosis of AD is complex and typically involves expensive and sometimes invasive tests not commonly available outside highly specialized clinical settings. Here, we developed an artific...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856143/ https://www.ncbi.nlm.nih.gov/pubmed/36672010 http://dx.doi.org/10.3390/brainsci13010028 |
_version_ | 1784873551269986304 |
---|---|
author | Agbavor, Felix Liang, Hualou |
author_facet | Agbavor, Felix Liang, Hualou |
author_sort | Agbavor, Felix |
collection | PubMed |
description | There is currently no simple, widely available screening method for Alzheimer’s disease (AD), partly because the diagnosis of AD is complex and typically involves expensive and sometimes invasive tests not commonly available outside highly specialized clinical settings. Here, we developed an artificial intelligence (AI)-powered end-to-end system to detect AD and predict its severity directly from voice recordings. At the core of our system is the pre-trained data2vec model, the first high-performance self-supervised algorithm that works for speech, vision, and text. Our model was internally evaluated on the ADReSSo (Alzheimer’s Dementia Recognition through Spontaneous Speech only) dataset containing voice recordings of subjects describing the Cookie Theft picture, and externally validated on a test dataset from DementiaBank. The AI model can detect AD with average area under the curve (AUC) of 0.846 and 0.835 on held-out and external test set, respectively. The model was well-calibrated (Hosmer-Lemeshow goodness-of-fit p-value = 0.9616). Moreover, the model can reliably predict the subject’s cognitive testing score solely based on raw voice recordings. Our study demonstrates the feasibility of using the AI-powered end-to-end model for early AD diagnosis and severity prediction directly based on voice, showing its potential for screening Alzheimer’s disease in a community setting. |
format | Online Article Text |
id | pubmed-9856143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98561432023-01-21 Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice Agbavor, Felix Liang, Hualou Brain Sci Article There is currently no simple, widely available screening method for Alzheimer’s disease (AD), partly because the diagnosis of AD is complex and typically involves expensive and sometimes invasive tests not commonly available outside highly specialized clinical settings. Here, we developed an artificial intelligence (AI)-powered end-to-end system to detect AD and predict its severity directly from voice recordings. At the core of our system is the pre-trained data2vec model, the first high-performance self-supervised algorithm that works for speech, vision, and text. Our model was internally evaluated on the ADReSSo (Alzheimer’s Dementia Recognition through Spontaneous Speech only) dataset containing voice recordings of subjects describing the Cookie Theft picture, and externally validated on a test dataset from DementiaBank. The AI model can detect AD with average area under the curve (AUC) of 0.846 and 0.835 on held-out and external test set, respectively. The model was well-calibrated (Hosmer-Lemeshow goodness-of-fit p-value = 0.9616). Moreover, the model can reliably predict the subject’s cognitive testing score solely based on raw voice recordings. Our study demonstrates the feasibility of using the AI-powered end-to-end model for early AD diagnosis and severity prediction directly based on voice, showing its potential for screening Alzheimer’s disease in a community setting. MDPI 2022-12-23 /pmc/articles/PMC9856143/ /pubmed/36672010 http://dx.doi.org/10.3390/brainsci13010028 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Agbavor, Felix Liang, Hualou Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice |
title | Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice |
title_full | Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice |
title_fullStr | Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice |
title_full_unstemmed | Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice |
title_short | Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice |
title_sort | artificial intelligence-enabled end-to-end detection and assessment of alzheimer’s disease using voice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856143/ https://www.ncbi.nlm.nih.gov/pubmed/36672010 http://dx.doi.org/10.3390/brainsci13010028 |
work_keys_str_mv | AT agbavorfelix artificialintelligenceenabledendtoenddetectionandassessmentofalzheimersdiseaseusingvoice AT lianghualou artificialintelligenceenabledendtoenddetectionandassessmentofalzheimersdiseaseusingvoice |